Business Card for Lisa Decker Sharma:


Sr Manager Systems, Analysis and Risk Management
San Francisco, CA area


1 Dna Way
South San Francisco, CA 94080

Tel: (650) 225-1000

Last updated on 2017-06-12


About Lisa Decker Sharma:

Lisa Decker Sharma works as an Sr Manager Systems, Analysis and Risk Management for Genentech, Inc. at San Francisco, CA. The company's webpage is http://www.gene.com. For email, phone number and executive profiles for Sr Manager Systems, Analysis and Risk Management and other executives of Genentech, Inc. at San Francisco, CA, check Genentech, Inc. at Joesdata.com. Not the Lisa Decker Sharma you are looking for? Do a quick search in our website and find other people named Lisa Decker Sharma.
Lisa Decker Sharma's Work History:
Manager Development Outsourcing and Contracts
Operations Process and Systems Group at Genentech
Manager Early Clinical Development Outsourcing and Contracts at Genentech
Manager Clinical Outsourcing at Genentech
Clinical Outsourcing Manager at Genentech
Supervisor
Purchasing Systems at Genentech
Senior Buyer
Group Buyer Medical Affairs at Genentech
R and D Buyer at Genentech.

Lisa Decker Sharma's Education:
University of California
Santa Barbara.

Lisa Decker Sharma's Co-workers:
As of May 11, 2021, Lisa Decker Sharma has 1358 co-workers under the company name Genentech, Inc. at Joesdata.com.

About Genentech, Inc.:

Genentech, Inc. is located at 1 Dna Way , South San Francisco, CA 94080. It has over 10K employees. Its revenue is over $1B.

Company News:
2018-09-13 19:18:41
FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
2018-09-13 17:30:39
FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
2018-09-06 19:24:23
Genentech to Present New Data from Its Extensive Lung Cancer Program at the 2018 World Conference on Lung Cancer (WCLC)
2018-08-30 17:30:48
Positive Phase III Results for Genentechs HEMLIBRA (emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors Published in New England Journal of Medicine
2018-08-13 19:19:15
FDA Grants Breakthrough Therapy Designation for Xolair (Omalizumab) for Food Allergies
2018-08-13 17:30:37
FDA Grants Breakthrough Therapy Designation for Xolair (Omalizumab) for Food Allergies
2018-07-25 17:42:26
Genentech Unveils Positive Phase II Results for the First-Ever Eye Implant to Achieve Sustained Delivery of a Biologic Medicine to Treat People With Wet Age-Related Macular Degeneration (AMD)
2018-07-25 17:31:17
Genentech Unveils Positive Phase II Results for the First-Ever Eye Implant to Achieve Sustained Delivery of a Biologic Medicine to Treat People With Wet Age-Related Macular Degeneration (AMD)
2018-07-20 18:54:47
Genentech to Present New Data Demonstrating the Breadth and Depth of Its Alzheimers Program at the Upcoming Alzheimer's Association International Conference (AAIC)
2018-07-20 17:30:51
Genentech to Present New Data Demonstrating the Breadth and Depth of Its Alzheimers Program at the Upcoming Alzheimer's Association International Conference (AAIC)

People in the same industry: